Transform Wealth LLC Has $3.10 Million Stock Holdings in HCA Healthcare, Inc. (NYSE:HCA)

Transform Wealth LLC raised its stake in shares of HCA Healthcare, Inc. (NYSE:HCAGet Rating) by 2.7% during the second quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 18,429 shares of the company’s stock after purchasing an additional 479 shares during the quarter. Transform Wealth LLC’s holdings in HCA Healthcare were worth $3,097,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other institutional investors also recently added to or reduced their stakes in the stock. Norges Bank bought a new stake in HCA Healthcare during the 4th quarter worth approximately $596,396,000. Sanders Capital LLC grew its position in HCA Healthcare by 16.9% during the 4th quarter. Sanders Capital LLC now owns 9,448,037 shares of the company’s stock worth $2,650,774,000 after acquiring an additional 1,365,582 shares during the last quarter. Magellan Asset Management Ltd grew its position in HCA Healthcare by 240,390.6% during the 1st quarter. Magellan Asset Management Ltd now owns 1,043,729 shares of the company’s stock worth $261,579,000 after acquiring an additional 1,043,295 shares during the last quarter. BlackRock Inc. grew its position in HCA Healthcare by 5.6% during the 1st quarter. BlackRock Inc. now owns 17,302,042 shares of the company’s stock worth $4,336,237,000 after acquiring an additional 925,010 shares during the last quarter. Finally, MFN Partners Management LP boosted its position in HCA Healthcare by 102.9% in the 1st quarter. MFN Partners Management LP now owns 1,261,201 shares of the company’s stock valued at $316,081,000 after buying an additional 639,701 shares during the last quarter. 65.75% of the stock is owned by institutional investors and hedge funds.

HCA Healthcare Price Performance

HCA traded down $5.40 during trading on Friday, hitting $188.66. 21,637 shares of the stock traded hands, compared to its average volume of 1,369,649. HCA Healthcare, Inc. has a twelve month low of $164.47 and a twelve month high of $279.02. The company has a market cap of $54.15 billion, a price-to-earnings ratio of 9.33, a PEG ratio of 1.51 and a beta of 1.72. The company has a debt-to-equity ratio of 87.46, a current ratio of 1.55 and a quick ratio of 1.32. The business has a 50 day moving average price of $205.76 and a 200 day moving average price of $214.90.

HCA Healthcare (NYSE:HCAGet Rating) last issued its quarterly earnings data on Friday, July 22nd. The company reported $4.21 earnings per share for the quarter, topping the consensus estimate of $3.67 by $0.54. The company had revenue of $14.82 billion for the quarter, compared to analysts’ expectations of $14.73 billion. HCA Healthcare had a net margin of 10.83% and a return on equity of 833.68%. HCA Healthcare’s revenue for the quarter was up 2.7% on a year-over-year basis. During the same quarter in the previous year, the firm posted $4.37 earnings per share. Equities research analysts forecast that HCA Healthcare, Inc. will post 17.09 earnings per share for the current fiscal year.

HCA Healthcare Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Friday, September 30th. Shareholders of record on Friday, September 16th will be given a dividend of $0.56 per share. The ex-dividend date of this dividend is Thursday, September 15th. This represents a $2.24 dividend on an annualized basis and a yield of 1.19%. HCA Healthcare’s dividend payout ratio (DPR) is currently 10.77%.

Insider Buying and Selling at HCA Healthcare

In related news, major shareholder Patricia F. Elcan acquired 325 shares of the company’s stock in a transaction dated Monday, July 25th. The shares were purchased at an average price of $198.66 per share, for a total transaction of $64,564.50. Following the completion of the acquisition, the insider now owns 89,337 shares of the company’s stock, valued at $17,747,688.42. The acquisition was disclosed in a filing with the SEC, which is available through the SEC website. Insiders own 1.50% of the company’s stock.

Analyst Ratings Changes

HCA has been the topic of a number of recent research reports. BMO Capital Markets lowered HCA Healthcare from a “market perform” rating to an “underperform” rating and decreased their price objective for the company from $233.00 to $160.00 in a research report on Wednesday, July 6th. Raymond James increased their price target on HCA Healthcare from $230.00 to $250.00 and gave the company an “outperform” rating in a research note on Friday, September 16th. Stephens raised their price objective on HCA Healthcare to $230.00 in a research note on Monday, July 25th. Oppenheimer set a $255.00 price target on HCA Healthcare in a research note on Monday, June 20th. Finally, Truist Financial raised their price objective on HCA Healthcare from $208.00 to $240.00 and gave the company a “buy” rating in a report on Monday, July 25th. One analyst has rated the stock with a sell rating, three have assigned a hold rating and sixteen have given a buy rating to the company. According to data from MarketBeat.com, HCA Healthcare has a consensus rating of “Moderate Buy” and an average target price of $239.14.

About HCA Healthcare

(Get Rating)

HCA Healthcare, Inc, through its subsidiaries, provides health care services company in the United States. The company operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.

Featured Articles

Institutional Ownership by Quarter for HCA Healthcare (NYSE:HCA)

Receive News & Ratings for HCA Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HCA Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.